From: Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society
Breast cancer-specific survival
Before IPTW
After IPTW
HRs (95% CI)
P value
Hormone receptor-positive
0.72 (0.44–1.17)
.188
.187
Hormone receptor-negative
0.64 (0.38–1.09)
.098
0.61 (0.35–1.05)
.075